Recent Finacing
Recent Raise
Atlantic Healthcare develops alicaforsen enema, an antisense oligonucleotide targeting ICAM-1 for inflammatory bowel diseases; conducting Phase 3 pouchitis trials across US, Canada, Europe, Israel, holding orphan and fast-track designations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors